Paul Stoffels on retiring from Galapagos; Boehringer Ingelheim switches up leadership
When the board of Belgian biotech Galapagos asked Paul Stoffels to become CEO, he told them he was only interested in doing the job for two to three years. Galapagos — a company he helped found ...
